US Stock MarketDetailed Quotes

MRK Merck & Co

Watchlist
  • 125.850
  • -1.870-1.46%
Close Jul 3 13:00 ET
  • 126.100
  • +0.250+0.20%
Post 16:56 ET
318.75BMarket Cap139.83P/E (TTM)

Merck & Co Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Merck & Co Earnings Date

Currency: USD

Period

Q1 2024 Earnings

Apr 25, 2024

Revenue(YoY)

15.78B

+8.89%
EPS(YoY)

1.87

+68.47%
Analyst Rating

Strong Buy

Jul 4, 2024

Merck & Co Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 17 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Oct 31, 20242024/Q3-- / 16.667B--
Jul 30, 20242024/Q2-- / 15.820B--
Apr 25, 20242024/Q115.775B / 15.204B--
Feb 1, 20242023/Q414.630B / 14.480B--
Oct 26, 20232023/Q315.962B / 15.273B--
DatePeriodRevenue/EstimateEarnings Call
Oct 31, 20242024/Q3-- / 16.667B--
Jul 30, 20242024/Q2-- / 15.820B--
Apr 25, 20242024/Q115.775B / 15.204B--
Feb 1, 20242023/Q414.630B / 14.480B--
Oct 26, 20232023/Q315.962B / 15.273B--

Unlock Free Earnings Estimates

Merck & Co Earnings Reports

  • Merck & Co | 10-Q: Quarterly report

    May 3 16:12 ET

  • Merck & Co | 10-K/A: Annual report (Amendment)

    Apr 11 16:11 ET

  • Merck & Co | 10-K: Annual report

    Feb 26 22:17 ET

  • Merck & Co | 10-Q: Q3 2023 Earnings Report

    Nov 3, 2023 16:10 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 4, 2024

    Strong Buy

    • Buy

      86.67%

    • Hold

      13.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept ESG Investing
    ESG Investing
    Intraday+0.43%
    Trump-Win Beneficial Stocks
    Trump-Win Beneficial Stocks
    Intraday-0.33%
    Cancer Research
    Cancer Research
    Intraday-0.93%